These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 14560776)
1. The myelodysplastic/myeloproliferative disorders: the interface. Bennett JM Hematol Oncol Clin North Am; 2003 Oct; 17(5):1095-100, v. PubMed ID: 14560776 [TBL] [Abstract][Full Text] [Related]
2. Focus on myeloproliferative diseases and myelodysplastic syndromes. Van Etten RA; Shannon KM Cancer Cell; 2004 Dec; 6(6):547-52. PubMed ID: 15607959 [No Abstract] [Full Text] [Related]
3. RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant. Ricci C; Fermo E; Corti S; Molteni M; Faricciotti A; Cortelezzi A; Lambertenghi Deliliers G; Beran M; Onida F Clin Cancer Res; 2010 Apr; 16(8):2246-56. PubMed ID: 20371679 [TBL] [Abstract][Full Text] [Related]
4. Myelodysplastic/myeloproliferative neoplasms. Cazzola M; Malcovati L; Invernizzi R Hematology Am Soc Hematol Educ Program; 2011; 2011():264-72. PubMed ID: 22160044 [TBL] [Abstract][Full Text] [Related]
5. [Chronic myelomonocytic leukemia (CMML): recent advances in molecular pathogenesis and treatment]. Harada Y; Harada H Rinsho Ketsueki; 2016 Feb; 57(2):147-55. PubMed ID: 26935632 [TBL] [Abstract][Full Text] [Related]
6. Treatment and outcomes for chronic myelomonocytic leukemia compared to myelodysplastic syndromes in older adults. Zandberg DP; Huang TY; Ke X; Baer MR; Gore SD; Smith SW; Davidoff AJ Haematologica; 2013 Apr; 98(4):584-90. PubMed ID: 23144192 [TBL] [Abstract][Full Text] [Related]
7. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders. Hall J; Foucar K Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271 [TBL] [Abstract][Full Text] [Related]
8. Special considerations in the management of patients with myelodysplastic myndrome / myeloproliferative neoplasm overlap syndromes during the SARS-CoV-2 pandemic. Patnaik MM; Lasho T; Padron E; McCullough K; Al-Kali A; Tefferi A; Zeidan AM; Gangat N; Savona M; Steensma DP; Solary E Am J Hematol; 2020 Aug; 95(8):E203-E208. PubMed ID: 32356322 [No Abstract] [Full Text] [Related]
9. Gene mutations differently impact the prognosis of the myelodysplastic and myeloproliferative classes of chronic myelomonocytic leukemia. Cervera N; Itzykson R; Coppin E; Prebet T; Murati A; Legall S; Vey N; Solary E; Birnbaum D; Gelsi-Boyer V Am J Hematol; 2014 Jun; 89(6):604-9. PubMed ID: 24595958 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of TET2 deletions in myeloid disorders: a fluorescence in situ hybridization analysis of 109 cases. Klaus M; Psaraki A; Mastrodemou S; Pyrovolaki K; Mavroudi I; Kalpadakis C; Papadaki HA Leuk Res; 2011 Mar; 35(3):413-5. PubMed ID: 21087791 [TBL] [Abstract][Full Text] [Related]
11. CMML: Clinical and molecular aspects. Itzykson R; Duchmann M; Lucas N; Solary E Int J Hematol; 2017 Jun; 105(6):711-719. PubMed ID: 28455647 [TBL] [Abstract][Full Text] [Related]
12. The relationship between the myelodysplastic syndromes and the myeloproliferative disorders. Bain BJ Leuk Lymphoma; 1999 Aug; 34(5-6):443-9. PubMed ID: 10492067 [TBL] [Abstract][Full Text] [Related]
13. Myelodysplastic and myeloproliferative disorders in children. Hasle H Curr Opin Pediatr; 2007 Feb; 19(1):1-8. PubMed ID: 17224655 [TBL] [Abstract][Full Text] [Related]
14. RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes. Janssen JW; Steenvoorden AC; Lyons J; Anger B; Böhlke JU; Bos JL; Seliger H; Bartram CR Proc Natl Acad Sci U S A; 1987 Dec; 84(24):9228-32. PubMed ID: 3122217 [TBL] [Abstract][Full Text] [Related]
16. Integrated Clinical Genotype-Phenotype Characteristics of STAT3-Mutated Myeloid Neoplasms. Ye MT; Zuo Z; Calin S; Ye F; He H; Kamata W; Yang Y; You MJ Clin Cancer Res; 2024 Oct; 30(20):4681-4689. PubMed ID: 38767620 [TBL] [Abstract][Full Text] [Related]
17. Making sense of the myelodysplastic/myeloproliferative neoplasms overlap syndromes. Tiu RV; Sekeres MA Curr Opin Hematol; 2014 Mar; 21(2):131-40. PubMed ID: 24378705 [TBL] [Abstract][Full Text] [Related]